ESR1 and breast cancer: Kondo et al reported that miR-206 was markedly decreased in ERα-positive human breast cancer tissues and that the introduction of miR-206 into estrogen-dependent MCF-7 breast cancer cells led to the suppression of ERα expression and growth inhibition (9).